Retinol binding protein 4 correlates with and is an early predictor of carotid atherosclerosis in type 2 diabetes mellitus patients

Journal of Biomedical Research

Volumn 29, Issue 6, 2015, Pages 451-455

  Feng, Shangyong ^a   Zhu, Yan ^a   Yan, Caifeng ^a   Wang, Yan ^a   Zhang, Zhenweng ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Retinol binding protein 4; Subclinical atherosclerosis; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ASSESSMENT OF HUMANS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHEMILUMINESCENCE IMMUNOASSAY; CHEMILUMINESCENCE IMMUNOASSAY KIT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; ELECTROCHEMILUMINESCENCE SANDWICH IMMUNOASSAY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FASTING PLASMA GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; INSULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84959101434     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.29.20140087     Document Type: Article

References (26)

1. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
2. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12):1090-1101.
3. Lorenz MW, von Kegler S, Steinmetz H, et al. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS)[J]. Stroke, 2006, 37(1):87-92.
4. Raila J, Henze A, Spranger J, et al. Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients[J]. Kidney In, 2007, 72(4):505-511.
5. Li F, Xia K, Sheikh MS, et al. Retinol binding protein 4 promotes hyperinsulinisminduced proliferation of rat aortic smooth muscle cells[J]. Mol Med Rep, 2014, 9(5):1634-1640.
6. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7):412-419.
7. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes[J]. Nutr Rev, 2007, 65(5):251-256.
8. Janke J, Engeli S, Boschmann M, et al. Retinol-binding protein 4 in human obesity[J]. Diabetes, 2006, 55(10):2805-2810.
9. Calo LA, Maiolino G, Pagnin E, et al. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelingdefences[J] Eur J ClinInvest, 2014, 44(6):567-572.
10. Huang G, Wang D, Khan UI, et al. Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: Cross-sectional analyses from the KEEPS Study[J]. CardiovascDiabetol, 2012, 11:52.
11. Qi Q, Yu Z, Ye X, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people[J]. J ClinEndocrinol Metab, 2007, 92(12):4827-4834.
12. Verges B, Guiu B, Cercueil JP, et al. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. ArteriosclerThrombVasc Biol, 2012, 32(12): 3050-3057.
13. Takebayashi K, Suetsugu M, Wakabayashi S, et al. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients[J]. J Clin Endocrinol Metab, 2007, 92(7):2712-2719.
14. Kashyap SR, Diab DL, Baker AR, et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort[J]. Obesity (Silver Spring), 2009, 17(9):1696-1701.
15. Lin CC, Lai MM, Li TC, et al. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome[J]. Diabetes Res Clin Pract, 2009, 85(1):24-29.
16. Mostafaie N, Sebesta C, Zehetmayer S, et al. Circulating retinol-binding protein 4 and metabolic syndrome in the elderly[J]. Wien Med Wochenschr, 2011, 161(21-22):505-510.
17. Rocha M, Banuls C, Bellod L, et al. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients[J]. PLoS One, 2013, 8(11):e78670.
18. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature, 2005, 436(7049):356-362.
19. Park H, Green MH, Shaffer ML. Association between serum retinol-binding protein 4 concentrations and clinical indices in subjects with type 2 diabetes: a metaanalysis[ J]. J Hum Nutr Diet, 2012, 25(4):300-310.
20. Moraes-Vieira PM, Yore MM, Dwyer PM, et al. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance[J]. Cell Metab, 2014, 19(3):512-526.
21. Norseen J, Hosooka T, Hammarstedt A, et al. Retinolbinding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism[J]. Mol Cell Biol, 2012, 32(10):2010-2019.
22. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects[J]. N Engl J Med, 2006, 354(24):2552-2563.
23. Yeste D, Vendrell J, Tomasini R, et al. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance[J]. Horm Res Paediatr, 2010, 73(5):335-340.
24. Goodman E, Graham TE, Dolan LM, et al. The relationship of retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents[J]. J Pediatr, 2009, 154(1):67-73.e1.
25. Balagopal P, Graham TE, Kahn BB, et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation[J]. J ClinEndocrinol Metab, 2007, 92(5):1971-1974.
26. Liu Y, Wang D, Li D, et al. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population[J]. DiabetolMetab Syndr, 2014, 6(1):25.